{"id":210,"date":"2024-01-18T11:32:00","date_gmt":"2024-01-18T17:32:00","guid":{"rendered":"https:\/\/www.rqmplus.com\/?post_type=scb-resources&#038;p=210"},"modified":"2025-06-05T15:49:18","modified_gmt":"2025-06-05T20:49:18","slug":"exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers","status":"publish","type":"scb-resources","link":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","title":{"rendered":"Exiting PFAS: A Strategic Blueprint for Medical Device Manufacturers"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" width=\"960\" height=\"540\" src=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/rqm_live_75_on_demand-min.webp\" alt=\"recorded 18 January 2024 exiting pfas a strategic blueprint for medical device manufacturers live #75\" class=\"wp-image-260\" style=\"width:550px\" srcset=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/rqm_live_75_on_demand-min.webp 960w, https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/rqm_live_75_on_demand-min-300x169.webp 300w, https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/rqm_live_75_on_demand-min-768x432.webp 768w\" sizes=\"(max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<p>With the forthcoming restrictions on Per- and Polyfluoroalkyl Substances (PFAS), medical device manufacturers are on the brink of a&nbsp;<em>significant<\/em>&nbsp;industry shift. PFAS, known for their versatile properties, have been integral in the production of various medical devices. However, with the phase-out of these substances by the end of 2025,&nbsp;<strong>manufacturers must navigate the transition with precision and strategic foresight<\/strong>.<\/p>\n\n\n\n<p>This session will begin with a short presentation to set the stage, and will be followed by a panel discussion bringing together RQM+&#8217;s leading experts in regulatory affairs, quality assurance, and lab services, to delineate a&nbsp;<strong>proactive approach for manufacturers<\/strong>.<\/p>\n\n\n\n<p>We will dissect the three-step process required to phase out PFAS used in medical devices, addressing the identification of alternative materials, the intricacies of materials testing and verification, and the critical steps for successful documentation submission to regulatory bodies.<\/p>\n\n\n\n<p>Key points of discussion:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Identification of Alternatives<\/strong>: Insights into how manufacturers can identify and source PFAS-free materials for medical devices, including potential redesign considerations.\u00a0<\/li>\n\n\n\n<li><strong>Testing and Validation<\/strong>: An overview of the materials testing, validation, and documentation process required to ensure compliance and maintain device quality and safety.\u00a0<\/li>\n\n\n\n<li><strong>Regulatory Strategy<\/strong>: Guidance on the submission of documentation to government agencies such as the FDA, and how to align with global regulatory expectations, including significant changes in the EU.\u00a0<\/li>\n\n\n\n<li><strong>Strategic Planning<\/strong>: Best practices for project management and ensuring a seamless transition, while minimizing disruptions to supply chains and operations.\u00a0<\/li>\n<\/ul>\n\n\n\n<p>Join us as we chart out the roadmap for an industry facing one of its most challenging transitions, ensuring that your devices remain compliant, safe, and on the leading edge of innovation.<\/p>\n\n\n\n<p>RSVP by completing the form and we&#8217;ll email connection details.<\/p>\n\n\n\n<p>Panelists:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Jaishankar (Jai) Kutty, Ph.D. \u2013 Vice President, Intelligence &amp; Innovation<\/li>\n\n\n\n<li>Kevin Rowland \u2013 Director of R&amp;D<\/li>\n\n\n\n<li>Taryn Meade \u2013 Director of Biological Evaluation Consulting<\/li>\n\n\n\n<li>James Wrenn \u2013 Director of Solutions Delivery<\/li>\n\n\n\n<li>Alexia Haralambous \u2013 Senior Principal (former FDA)\u00a0<em>[Newly added!]<\/em><\/li>\n<\/ul>\n\n\n\n<p><em>BONUS: If you want to get the most out of the session, be sure to watch this primer from by Jai beforehand. This video outlines the basics, and we&#8217;ll dive deeper and answer your questions during the discussion.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>With the forthcoming restrictions on Per- and Polyfluoroalkyl Substances (PFAS), medical device manufacturers are on the brink of a&nbsp;significant&nbsp;industry shift&#8230;.<\/p>\n","protected":false},"author":2,"featured_media":165,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"resource-type":[6],"topic":[9],"class_list":["post-210","scb-resources","type-scb-resources","status-publish","has-post-thumbnail","hentry","resource-type-rqm-live","topic-regulatory-quality"],"acf":[],"card_info":{"title":"Exiting PFAS: A Strategic Blueprint for Medical Device Manufacturers","link":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","link_target":"_self","name":"RQM+ Live!","slug":"rqm-live","thumbnail":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg","excerpt":"With the forthcoming restrictions on Per- and Polyfluoroalkyl Substances (PFAS), medical device manufacturers are on the brink of a&nbsp;significant&nbsp;industry shift....","display_date":"January 18, 2024"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+<\/title>\n<meta name=\"description\" content=\"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+\" \/>\n<meta property=\"og:description\" content=\"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/\" \/>\n<meta property=\"og:site_name\" content=\"RQM+\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RQMplus\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-05T20:49:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1799\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/\",\"url\":\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/\",\"name\":\"PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg\",\"datePublished\":\"2024-01-18T17:32:00+00:00\",\"dateModified\":\"2025-06-05T20:49:18+00:00\",\"description\":\"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg\",\"width\":1799,\"height\":1200,\"caption\":\"Lab equipment\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rqmplus.com\/#website\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"name\":\"RQM+\",\"description\":\"Evolving MedTech\",\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rqmplus.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rqmplus.com\/#organization\",\"name\":\"RQM+\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"width\":696,\"height\":696,\"caption\":\"RQM+\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/RQMplus\",\"https:\/\/x.com\/RQMplus\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+","description":"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","og_locale":"en_US","og_type":"article","og_title":"PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+","og_description":"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.","og_url":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","og_site_name":"RQM+","article_publisher":"https:\/\/www.facebook.com\/RQMplus","article_modified_time":"2025-06-05T20:49:18+00:00","og_image":[{"width":1799,"height":1200,"url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@RQMplus","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","url":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/","name":"PFAS Phase-Out Strategies for Medical Device Manufacturers | RQM+","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage"},"image":{"@id":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg","datePublished":"2024-01-18T17:32:00+00:00","dateModified":"2025-06-05T20:49:18+00:00","description":"Watch our on-demand panel discussion to learn proactive approaches for transitioning away from PFAS in medical devices, including alternative materials, testing, and regulatory strategies.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/resources\/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers\/#primaryimage","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/live_75_promo_image-min.jpg","width":1799,"height":1200,"caption":"Lab equipment"},{"@type":"WebSite","@id":"https:\/\/www.rqmplus.com\/#website","url":"https:\/\/www.rqmplus.com\/","name":"RQM+","description":"Evolving MedTech","publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rqmplus.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rqmplus.com\/#organization","name":"RQM+","url":"https:\/\/www.rqmplus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","width":696,"height":696,"caption":"RQM+"},"image":{"@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RQMplus","https:\/\/x.com\/RQMplus"]}]}},"_links":{"self":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources\/210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources"}],"about":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/types\/scb-resources"}],"author":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources\/210\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media\/165"}],"wp:attachment":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media?parent=210"}],"wp:term":[{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/resource-type?post=210"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/topic?post=210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}